IPBD
Novel Targeted Drugs and Their Introduction to the Clinic Phil Bedard MD, FRCP(C) Division of Medical Oncology/Hematology Drug Development Program.
Owensboro Economic Development Strategy
#39246
A Bayesian Industry Approach to Phase 1 Combination Trials in Oncology
2014-10-22 EUGM | ROYCHAUDHURI | Phase I Combination Trials
Phase I dose escalation studies in Oncology: a call for on-study safety and flexibility Bill Mietlowski, Biometrics and Data Management, Novartis Oncology.
Phase I Trial Designs Jud Blatchford, PhD Colorado School of Public Health January 30 th, 2013.
Dose finding designs driven by immunotherapy outcomes with Application to a metastatic melanoma phase I trial Elizabeth Garrett-Mayer, PhD Cody Chiuzan,
This house believes that FOLFIRINOX is the best treatment for patients with metastatic pancreatic adenocarcinoma Pro Marc YCHOU Montpellier.
SK Sandhu 1,2 , R Wenham 3 , G Wilding 4 , M McFadden 5 , L Sun 5 ,
Richard Gorlick and George Demetri, Co-PIs
